These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3471528)

  • 1. Combination chemotherapy with aclarubicin in metastatic breast cancer.
    Simader H; Hausmaninger H; Fereberger W; Samonigg H
    Eur J Haematol Suppl; 1987; 47():71-6. PubMed ID: 3471528
    [No Abstract]   [Full Text] [Related]  

  • 2. Aclarubicin in single agent and combined chemotherapy of acute myeloid leukaemias.
    Mitrou PS
    Eur J Haematol Suppl; 1987; 47():59-66. PubMed ID: 3471526
    [No Abstract]   [Full Text] [Related]  

  • 3. Daunorubicin versus aclarubicin in combination with cytarabine and thioguanine in elderly patients with acute nonlymphocytic leukemia, a preliminary report.
    Björkholm M; Killander A
    Eur J Haematol Suppl; 1987; 47():49-54. PubMed ID: 3471525
    [No Abstract]   [Full Text] [Related]  

  • 4. [Chemotherapy combining vindesine, thiotepa and methotrexate in metastatic breast cancer after failure of a combination containing anthracycline. Results of a prospective phase II trial].
    Comoz M; Chevallier B; Bastit P
    Bull Cancer; 1988; 75(3):281-3. PubMed ID: 3130910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra-arterial infusion chemotherapy as an induction therapy in multidisciplinary treatment for locally advanced breast cancer. A long-term follow-up study.
    Koyama H; Nishizawa Y; Wada T; Kabuto T; Shiba E; Iwanaga T; Terasawa T; Wada A
    Cancer; 1985 Aug; 56(4):725-9. PubMed ID: 3926292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aclacinomycin-A in the induction treatment of childhood acute myelogenous leukemia.
    Fink FM; Grümayer ER; Kardos G; Revesz T; Gadner H; Schuler D
    Haematol Blood Transfus; 1987; 30():393-8. PubMed ID: 3305209
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial.
    Gockerman JP; Raney M; Logan T
    Cancer Treat Rep; 1985 Sep; 69(9):1029-30. PubMed ID: 3861247
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined chemotherapy with cisplatin and aclarubicin hydrochloride for metastatic brain tumors].
    Tanaka T; Kobayashi T; Kida Y
    No Shinkei Geka; 1988 Jan; 16(1):23-8. PubMed ID: 3163105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful treatment of acute megakaryoblastic leukaemia.
    Ninomiya H; Nakazawa M; Shibuya A; Aoki Y; Nagasawa T; Abe T
    Scand J Haematol; 1986 Feb; 36(2):147-53. PubMed ID: 3458290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combination chemotherapy of N(4)-behenoyl-1-beta-arabinofuranosylcytosine, aclarubicin, 6-MP, and prednisolone (BH-AC. AMP therapy) for adult acute non-lymphocytic leukemia].
    Ishige K; Takagi T; Oguro M
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1475-9. PubMed ID: 6588925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Administration of aclarubicin in malignant lymphoma].
    Takagi T; Oguro M; Iwabuchi K
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1540-1. PubMed ID: 6575729
    [No Abstract]   [Full Text] [Related]  

  • 12. [Full remission of acute non-lymphatic leukemia lasting for 16 months following combination therapy with aclacinomycin A].
    Beck JD
    Monatsschr Kinderheilkd; 1986 Aug; 134(8):547-9. PubMed ID: 3464845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trials of combination chemotherapy using cis-platinum with aclarubicin in intracranial rhabdomyosarcoma].
    Wakabayashi T; Yoshida J; Ishiyama J; Kageyama N
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2374-7. PubMed ID: 3300563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of aclarubicin in patients with breast cancer previously untreated with adriamycin.
    Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Mechl Z; Nekulova M; Kolariĉ K; Tomek R; Röthig J
    Eur J Haematol Suppl; 1987; 47():67-9. PubMed ID: 3471527
    [No Abstract]   [Full Text] [Related]  

  • 15. Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study.
    Ettinger DS; Finkelstein DM; Harper GR; Ruckdeschel JC; Chang AY; Camacho FJ; Marsh JC; Silber R; Wolter JM
    Cancer Treat Rep; 1985 Sep; 69(9):1033-4. PubMed ID: 3861248
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of acute non-lymphocytic leukemia in Saitama Cancer Center.
    Sampi K; Sakurai M; Kaneko Y; Hattori M
    Anticancer Res; 1985; 5(3):293-6. PubMed ID: 4015043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response of ovarian cancer to combined cytotoxic agents in the subrenal capsule assay: Part I.
    Mäenpää J; Kangas L; Grönroos M
    Obstet Gynecol; 1985 Nov; 66(5):708-13. PubMed ID: 3932908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin for metastatic breast cancer: time for a change?
    Muggia F
    Cancer Invest; 2003; 21(6):967-8. PubMed ID: 14735701
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental and clinical studies on aclarubicin in the treatment of solid tumors.
    Kumai K; Kubota T; Ishibiki K; Abe O
    Biomed Pharmacother; 1984; 38(7):332-7. PubMed ID: 6596963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental chemotherapy of human breast carcinomas transplanted into nude mice].
    Koh J; Asanuma F; Kurihara H; Konno H; Kubouchi K; Ikeda T; Enomoto K; Ishibiki K; Abe O; Kubota T
    Nihon Gan Chiryo Gakkai Shi; 1984 Aug; 19(7):1488-95. PubMed ID: 6440935
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.